Stay updated on Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial page.
Latest updates to the Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedMelanoma-related topics and MedlinePlus Genetics links were added, and publication attribution language from PubMed was updated; these changes are editorial and do not affect study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check28 days agoChange DetectedThe general banner about government funding and potential delays has been removed from the page; the study details and related links remain visible and accessible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check35 days agoChange DetectedThe page no longer lists 'Melanoma' as a related topic and removes the 'MedlinePlus Genetics' related topic.SummaryDifference0.2%
- Check43 days agoChange DetectedThe two screenshots show minor formatting and layout adjustments on the Study Details page without any updates to core trial information such as the title, interventions, eligibility criteria, primary outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check57 days agoChange DetectedAdded MedlinePlus Genetics topic: Melanoma. No deletions.SummaryDifference0.2%
- Check64 days agoChange DetectedRemoved a MedlinePlus Genetics topic on Melanoma; no new topics added.SummaryDifference0.2%
Stay in the know with updates to Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial page.